PlainRecalls
FDA Drug Low Class III Terminated

Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37

Reported: March 20, 2019 Initiated: February 21, 2019 #D-0996-2019

Product Description

Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37

Reason for Recall

Failed Dissolution Specifications

Details

Recalling Firm
Lannett Company Inc.
Units Affected
14,448 bottles
Distribution
Nationwide, including Puerto Rico.
Location
Seymour, IN

Frequently Asked Questions

What product was recalled?
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37. Recalled by Lannett Company Inc.. Units affected: 14,448 bottles.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on March 20, 2019. Severity: Low. Recall number: D-0996-2019.